Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,666
archived clinical trials in
Hospital

Aerosolized Surfactant in Neonatal RDS
Aerosolized Survanta in Neonatal Respiratory Distress Syndrome: Phase I/II Study
Status: Enrolling
Updated:  12/31/1969
Hutzel Women's Hospital
mi
from
Detroit, MI
Aerosolized Surfactant in Neonatal RDS
Aerosolized Survanta in Neonatal Respiratory Distress Syndrome: Phase I/II Study
Status: Enrolling
Updated: 12/31/1969
Hutzel Women's Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Methadone in Ambulatory Surgery
Methadone in Ambulatory Surgery
Status: Enrolling
Updated:  12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Methadone in Ambulatory Surgery
Methadone in Ambulatory Surgery
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)
A Phase I Study Using Most Closely HLA-matched Cytomegalovirus-specific T Lymphocytes for the Treatment of Cytomegalovirus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-C)
Status: Enrolling
Updated:  12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)
A Phase I Study Using Most Closely HLA-matched Cytomegalovirus-specific T Lymphocytes for the Treatment of Cytomegalovirus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-C)
Status: Enrolling
Updated: 12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)
A Phase I Study Using Most Closely HLA-matched Cytomegalovirus-specific T Lymphocytes for the Treatment of Cytomegalovirus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-C)
Status: Enrolling
Updated:  12/31/1969
Methodist Hospital System
mi
from
Houston, TX
Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)
A Phase I Study Using Most Closely HLA-matched Cytomegalovirus-specific T Lymphocytes for the Treatment of Cytomegalovirus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-C)
Status: Enrolling
Updated: 12/31/1969
Methodist Hospital System
mi
from
Houston, TX
Click here to add this to my saved trials
What is the Optimal Stiffness and Height of a Running-specific Prosthesis?
What is the Optimal Stiffness and Height of a Running-specific Prosthesis?
Status: Enrolling
Updated:  12/31/1969
University of Colorado, Boulder
mi
from
Boulder, CO
What is the Optimal Stiffness and Height of a Running-specific Prosthesis?
What is the Optimal Stiffness and Height of a Running-specific Prosthesis?
Status: Enrolling
Updated: 12/31/1969
University of Colorado, Boulder
mi
from
Boulder, CO
Click here to add this to my saved trials
Cerebral Oxygenation in Total Hip Arthroplasty Patients
Cerebral Near-Infrared Spectroscopy and Hypotensive Anesthesia in Patients Undergoing Total Hip Arthroplasty
Status: Enrolling
Updated:  12/31/1969
Hospital for Special Surgery
mi
from
New York, NY
Cerebral Oxygenation in Total Hip Arthroplasty Patients
Cerebral Near-Infrared Spectroscopy and Hypotensive Anesthesia in Patients Undergoing Total Hip Arthroplasty
Status: Enrolling
Updated: 12/31/1969
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Prevention of Bone Loss After Acute SCI by Zoledronic Acid
Prevention of Bone Loss After Acute SCI by Zoledronic Acid: Durability, Effect on Bone Strength, and Use of Biomarkers to Guide Therapy
Status: Enrolling
Updated:  12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Prevention of Bone Loss After Acute SCI by Zoledronic Acid
Prevention of Bone Loss After Acute SCI by Zoledronic Acid: Durability, Effect on Bone Strength, and Use of Biomarkers to Guide Therapy
Status: Enrolling
Updated: 12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Prevention of Bone Loss After Acute SCI by Zoledronic Acid
Prevention of Bone Loss After Acute SCI by Zoledronic Acid: Durability, Effect on Bone Strength, and Use of Biomarkers to Guide Therapy
Status: Enrolling
Updated:  12/31/1969
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Prevention of Bone Loss After Acute SCI by Zoledronic Acid
Prevention of Bone Loss After Acute SCI by Zoledronic Acid: Durability, Effect on Bone Strength, and Use of Biomarkers to Guide Therapy
Status: Enrolling
Updated: 12/31/1969
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Status: Enrolling
Updated:  12/31/1969
University of Florida Health
mi
from
Gainesville, FL
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Status: Enrolling
Updated: 12/31/1969
University of Florida Health
mi
from
Gainesville, FL
Click here to add this to my saved trials
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Jacksonville, FL
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Status: Enrolling
Updated:  12/31/1969
Isomark, LLC
mi
from
Madison, WI
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Status: Enrolling
Updated: 12/31/1969
Isomark, LLC
mi
from
Madison, WI
Click here to add this to my saved trials
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin-Madison
mi
from
Madison, WI
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
Helen Keller Hospital
mi
from
Sheffield, AL
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
Helen Keller Hospital
mi
from
Sheffield, AL
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
UCSF School of Medicine
mi
from
San Francisco, CA
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
UCSF School of Medicine
mi
from
San Francisco, CA
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
Jackson Memorial Hospital
mi
from
Miami, FL
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
Albany Medical Center Hospital
mi
from
Albany, NY
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
Albany Medical Center Hospital
mi
from
Albany, NY
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
Stony Brook Medicine
mi
from
Stony Brook, NY
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
Stony Brook Medicine
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
First Street Surgical Center
mi
from
Bellaire, TX
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
First Street Surgical Center
mi
from
Bellaire, TX
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
Memorial Hermann-Memorial City Hospital
mi
from
Houston, TX
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
Memorial Hermann-Memorial City Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
Victory Medical Center Houston
mi
from
Houston, TX
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
Victory Medical Center Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated:  12/31/1969
University Hospital
mi
from
Besançon,
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Randomised, Double-blind, Placebo-controlled Phase III Study of APD421 (Amisulpride for IV Injection) as Combination Prophylaxis Against Post-operative Nausea and Vomiting in High-risk Patients
Status: Enrolling
Updated: 12/31/1969
University Hospital
mi
from
Besançon,
Click here to add this to my saved trials
The Brave Initiative: Bringing Rehabilitation to American Veterans in an Enriched Environment
Harnessing Neuroplasticity to Promote Rehabilitation: Constraint-Induced (CI) Therapy for Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
The Brave Initiative: Bringing Rehabilitation to American Veterans in an Enriched Environment
Harnessing Neuroplasticity to Promote Rehabilitation: Constraint-Induced (CI) Therapy for Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Clinical Trial of a Serious Game for Individuals With SCI/D
Evaluating the Effectiveness of a Serious Game to Enhance Self-Management Skills Among Adolescents and Young Adults With Spinal Cord Dysfunction
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Clinical Trial of a Serious Game for Individuals With SCI/D
Evaluating the Effectiveness of a Serious Game to Enhance Self-Management Skills Among Adolescents and Young Adults With Spinal Cord Dysfunction
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Effect of Bupivacaine-infused Fibrin Sealant Application on Post-tonsillectomy Pain & Hemorrhage
Effect of Bupivacaine-infused Fibrin Sealant Application on Post-tonsillectomy Pain & Hemorrhage: a Clinical Trial.
Status: Enrolling
Updated:  12/31/1969
Riley Children's Hospital
mi
from
Indianapolis, IN
Effect of Bupivacaine-infused Fibrin Sealant Application on Post-tonsillectomy Pain & Hemorrhage
Effect of Bupivacaine-infused Fibrin Sealant Application on Post-tonsillectomy Pain & Hemorrhage: a Clinical Trial.
Status: Enrolling
Updated: 12/31/1969
Riley Children's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Prospective Trial Evaluating the Effect of Closed Suction Drainage Versus Straight Drainage After Distal Pancreatectomy
Prospective Trial Evaluating the Effect of Closed Suction Drainage Versus Straight Drainage After Distal Pancreatectomy
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Prospective Trial Evaluating the Effect of Closed Suction Drainage Versus Straight Drainage After Distal Pancreatectomy
Prospective Trial Evaluating the Effect of Closed Suction Drainage Versus Straight Drainage After Distal Pancreatectomy
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Safety of ahSC in Chronic SCI With Rehabilitation
The Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Chronic Spinal Cord Injury (SCI) Receiving Rehabilitation
Status: Enrolling
Updated:  12/31/1969
University of Miami
mi
from
Miami, FL
The Safety of ahSC in Chronic SCI With Rehabilitation
The Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Chronic Spinal Cord Injury (SCI) Receiving Rehabilitation
Status: Enrolling
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Echo vs. EGDT in Severe Sepsis and Septic Shock
Echocardiography-Guided Resuscitation in Severe Sepsis and Septic Shock Vs. Early Goal-Directed Therapy: Pilot Study
Status: Enrolling
Updated:  12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Echo vs. EGDT in Severe Sepsis and Septic Shock
Echocardiography-Guided Resuscitation in Severe Sepsis and Septic Shock Vs. Early Goal-Directed Therapy: Pilot Study
Status: Enrolling
Updated: 12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Rancho Los Amigos/USC
mi
from
Los Angeles, CA
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Rancho Los Amigos/USC
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Shepherd Center
mi
from
Atlanta, GA
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Shepherd Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Indiana University
mi
from
Indianapolis, IN
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Washington University
mi
from
Saint Louis, MO
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University/Magee Rehabilitation
mi
from
Philadelphia, PA
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University/Magee Rehabilitation
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Stanford University/Santa Clara Valley Medical Center
mi
from
San Jose, CA
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Stanford University/Santa Clara Valley Medical Center
mi
from
San Jose, CA
Click here to add this to my saved trials
Aspiration in Acute Respiratory Failure Survivors
Aspiration in Acute Respiratory Failure Survivors
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Aspiration in Acute Respiratory Failure Survivors
Aspiration in Acute Respiratory Failure Survivors
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Aspiration in Acute Respiratory Failure Survivors
Aspiration in Acute Respiratory Failure Survivors
Status: Enrolling
Updated:  12/31/1969
Boston University Medical Center
mi
from
Boston, MA
Aspiration in Acute Respiratory Failure Survivors
Aspiration in Acute Respiratory Failure Survivors
Status: Enrolling
Updated: 12/31/1969
Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Aspiration in Acute Respiratory Failure Survivors
Aspiration in Acute Respiratory Failure Survivors
Status: Enrolling
Updated:  12/31/1969
Yale University
mi
from
New Haven, CT
Aspiration in Acute Respiratory Failure Survivors
Aspiration in Acute Respiratory Failure Survivors
Status: Enrolling
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Project 4A: Inspiratory Muscle Training and Diaphragm Strength
Study: Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care: Project 4A: Inspiratory Muscle Training and Diaphragm Strength
Status: Enrolling
Updated:  12/31/1969
UF Health Shands Hospital at the University of Florida
mi
from
Gainesville, FL
Project 4A: Inspiratory Muscle Training and Diaphragm Strength
Study: Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care: Project 4A: Inspiratory Muscle Training and Diaphragm Strength
Status: Enrolling
Updated: 12/31/1969
UF Health Shands Hospital at the University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Long Term Cognitive Impact of Pediatric Acute Renal Injury
Long Term Cognitive Impact of Pediatric Acute Renal Injury
Status: Enrolling
Updated:  12/31/1969
UF Health
mi
from
Gainesville, FL
Long Term Cognitive Impact of Pediatric Acute Renal Injury
Long Term Cognitive Impact of Pediatric Acute Renal Injury
Status: Enrolling
Updated: 12/31/1969
UF Health
mi
from
Gainesville, FL
Click here to add this to my saved trials
Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital, Harvard University
mi
from
Boston, MA
Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital, Harvard University
mi
from
Boston, MA
Click here to add this to my saved trials